Articles by Brian Haggert, MS
Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products
ByDavid Hartenbaum, MD,Michael Stek, MD,Brian Haggert, MS,Dan Holder, PhD,John Earle, PhD,Alice Wysocki, MS,Bernard Schwartz, MD, PhD